Can preoperative CEA and CA19-9 serum concentrations suggest metastatic disease in colorectal cancer patients?
CONCLUSION: Our study showed that tumor makers, CEA and CA19-9, can be used as diagnostic factors regarding the severity of CRC specifically to suggest metastatic disease in CRC.
PMID: 28315907 [PubMed - as supplied by publisher]
Source: Hellenic Journal of Nuclear Medicine - Category: Nuclear Medicine Tags: Hell J Nucl Med Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Colorectal Cancer | Hepatocellular Carcinoma | Liver | Liver Cancer | Nuclear Medicine | Statistics | Study | Urology & Nephrology